Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Gloucester Pharma Reports on Clinical Study
Making Sense of the PSA Test for Prostate Cancer
Biovex Begins Phase II Clinical Trials
Mobile Phones Not Linked To increased Risk Of Brain Tumours
Milestone Reached in Oncology Collaboration
New Chair for Top Academic Surgeon
Cougar Biotechnology Announces Initiation of Phase I/II Trial for CB7630 (Abiraterone Acetate)
Promising New Anti-Cancer Drug Targets Malignant Melanoma Protein
Research published today by scientists from The Institute of Cancer Research shows that a protein found to be damaged and therefore overactive in 70% of cases of malignant melanoma - the most deadly form of skin cancer - can be targeted by the promising new anti-cancer drug 17AAG.
PIramed Signs Collaboration with Genentech to Develop New Class of Anti-Cancer Drugs
NCRI Informatics Initiative Wins Award
Breathe Easy - International Lung Cancer Awareness Day